Description of the medicine: Rumalonum (Rumalonum)
RUMALON (Rumalonum) *.
A preparation containing cartilage extract from young animals and bone marrow extract.
Used for diseases of the joints, accompanied by degenerative changes in the cartilage tissue (arthrosis, spondylosis, etc.).
Intramuscularly administered deeply: on the first day, 0.3 ml, after 2 days, 0.5 ml, then 1 ml 3 times a week. The course of treatment is 5-6 weeks. The effect (reduction of pain, improved mobility) is usually observed 2 to 3 weeks after the start of treatment. If necessary, treatment courses are repeated.
For inflammatory joint diseases (rheumatoid arthritis), rumalon should not be used; there is evidence of the possibility of exacerbation and aggravation of the course of the disease.
Release form: in ampoules of 1 ml.